Healthcare - Biotechnology - NASDAQ - US
$ 4.49
-7.8 %
$ 3.13 B
Market Cap
-5.41
P/E
CASH FLOW STATEMENT
-367 M
OPERATING CASH FLOW
-30.5 M
INVESTING CASH FLOW
558 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
ImmunityBio, Inc.
| Net Income | -583 M |
| Depreciation & Amortization | 18.5 M |
| Capital Expenditures | -30.6 M |
| Stock-Based Compensation | 49.2 M |
| Change in Working Capital | 3.98 M |
| Others | 155 M |
| Free Cash Flow | -397 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||
| Net Income | (583.2) | (417.3) | (349.8) | (224.2) | (160.2) | (96.2) | (96.4) | (120.8) | (236.9) | (6.2) | (2.0) |
| Depreciation & Amortization | 18.5 | 18.3 | 14.2 | 12.7 | 14.0 | 9.6 | 5.6 | 3.6 | 1.5 | 0.1 | 4 K |
| Deferred Income Tax | 0 | 4 K | 8 K | (2.9) | 8 K | (0.5) | (0.5) | (0.6) | (0.3) | 0 | 0 |
| Stock Based Compensation | 49.2 | 40.2 | 57.2 | 2.2 | 3.4 | 2.0 | 37.0 | 73.9 | 211.2 | 0 | 0 |
| Other Operating Activities | 144.8 | 29.4 | 23.1 | 24.1 | 6.2 | 44.6 | 50.3 | 81.7 | 212.4 | (61.0) | (0.4) |
| Change in Working Capital | 4.0 | (8.0) | (19.1) | 16.4 | (15.6) | (0.6) | 3.2 | 3.8 | 0.3 | 61.0 | 0.9 |
| Cash From Operations | (366.8) | (337.5) | (274.4) | (171.7) | (152.1) | (63.4) | (48.8) | (38.6) | (25.3) | (5.4) | (0.7) |
| INVESTING CASH FLOW | |||||||||||
| Capital Expenditures | (30.6) | (99.4) | (33.6) | (1.7) | (4.3) | (13.1) | (34.8) | (6.6) | (2.2) | (0.3) | 3 K |
| Other Items | 0.1 | 126.7 | (51.3) | (18.1) | 22.8 | 70.2 | 134.4 | (107.1) | (173.0) | 0 | 0 |
| Cash From Investing Activities | (30.5) | 27.3 | (84.9) | (19.8) | 18.6 | 57.1 | 99.6 | (113.7) | (175.2) | (0.3) | 3 K |
| FINANCING CASH FLOW | |||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | (2.5) | (0.2) | (15.2) | (15.8) | (4.8) | 0 | 0 |
| Total Debt Repaid | 258.6 | 174.1 | 338.5 | 63.7 | 47.7 | (0.5) | (19.9) | 32 K | (0.1) | 53 K | 1 K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 189.6 | (0.9) | 2.4 | 0.7 | 39.1 | (0.1) | (1.0) | (1.1) | (2.4) | 1 | 0 |
| Cash From Financing Activities | 558.3 | 233.6 | 505.4 | 150.7 | 114.3 | (0.8) | (35.0) | (15.6) | 317.3 | 64.4 | 0.9 |
| CHANGE IN CASH | |||||||||||
| Net Change In Cash | 160.8 | (76.3) | 146.2 | (40.9) | (19.3) | (7.1) | 15.8 | (167.8) | 116.8 | 58.8 | 0.2 |
| FREE CASH FLOW | |||||||||||
| Free Cash Flow | (397.3) | (436.9) | (308.0) | (173.4) | (156.4) | (76.5) | (83.6) | (45.2) | (27.5) | (5.7) | (0.7) |